Steadfast in versatility : the substrate of a multi-modal practice

The research is about inventing ways to produce spaces of inspiration that catalyse curiosity and generous, resilient creativity which goes beyond the local, national or regional borders, enhancing public space, while operating in the transforming context of Estonia. The work evidences certain ‘joyful’ approaches to publicness in design activity, in which the search for functional realities not only incorporates but immerses itself in and builds upon other disciplines as well as on institutional, ideological and structural processes. When practice’s activities propagate through a multiplicity of expressions (simultaneous drawing, model-making, installations, construction supervision, texts, and so on), the set of ‘devices’ with, upon and within which the designer operates could be called the practice’s substratum (substrate). The research poses a question that to evolve a practice, is it necessary to transform its structure, purpose or agenda, or is it a question of how to renew its substrate? A closer look at an existing practice reveals how a practice’s substratum might shift in response to a contextual change. A multi-modal versatile practice bears within it the capacity to facilitate (positive) or to resist (negative) societal change. The research points to the potential for some specific open-ended ‘protocols’ to emerge from the observations offered

Intergenerational support among migrant families in Europe

Intergenerational support is important throughout the individual life course and a major mechanism of cultural continuity. In this study, we analyse support between older parents and their adult children among international migrant and non-migrant populations in North, Centre and Southern Europe. Data from the Survey of Health, Ageing and Retirement in Europe are used to compare upward and downward practical support, grandparenting, and frequency of contact among 62,213 parent–child dyads. Findings indicate limited differences in support between migrants and non-migrants as well as between migrants of various origins. However, persistent differences in intergenerational support across Europe along a north–south gradient are found irrespective of migrant status

Effect of prevention measures on incidence of human listeriosis, France, 1987-1997.

To assess the impact of preventive measures by the food industry, we analyzed food monitoring data as well as trends in the incidence of listeriosis estimated through three independent sources: the National Reference Center of Listeriosis; a laboratory-based active surveillance network; and two consecutive nationwide surveys of public hospital laboratories. From 1987 to 1997, the incidence of listeriosis decreased by an estimated 68%. A substantial reduction in the proportion of Listeria monocytogenes-contaminated products was observed at the retail level. The temporal relationship between prevention measures by the food industry, reduction in L. monocytogenes-contaminated foodstuffs, and reduction in listeriosis incidence suggests a causal relationship and indicates that a substantial part of the reduction in illness is related to prevention efforts

ENDOCRINOLOGY IN THE TIME OF COVID-19 Clinical management of neuroendocrine neoplasms (NENs)

In viral pandemics, most specifically Covid-19, many patients with neuroendocrine neoplasms (NENs), including phaeochromocytomas, paragangliomas and medullary thyroid carcinoma, may develop Covid-19 in a mild or severe form, or be concerned about the influence of viral infection relative to their anti-tumoral therapy. In general, newly presenting patients should be assessed, and patients recently receiving chemotherapy, targeted therapy or radionuclide therapy, or showing tumour growth, should be closely followed. For previously diagnosed patients, who have indolent disease, some delay in routine follow-up or treatment may not be problematic. However, patients developing acute secretory syndromes due to functional neuroendocrine neoplasms (such as of the pancreas, intestine or lung), phaeochromocytomas and paragangliomas, will require prompt treatment. Patients with life-threatening Covid-19-related symptoms should be urgently treated and long-term anti-tumoral treatments may be temporarily delayed. In patients with especially aggressive NENs, a careful judgement should be made regarding the severity of any Covid-19 illness, tumour grade, and the immunosuppressant effects of any planned chemotherapy, immunotherapy (e.g. interferon-alpha), targeted therapy or related treatment. In other cases, especially patients with completely resected NENs, or who are under surveillance for a genetic disorder, a telephone or delayed consultation may be in order, balancing the risk of a delay against that of the possible development of Covid-19.Peer reviewe

Current and future technical, economic and environmental feasibility of maize and wheat residues supply for biomass energy application:Illustrated for South Africa

AbstractThis study assessed the feasibility of mobilising maize and wheat residues for large-scale bioenergy applications in South Africa by establishing sustainable residue removal rates and cost of supply based on different production regions. A key objective was to refine the methodology for estimating crop residue harvesting for bioenergy use, while maintaining soil productivity and avoiding displacement of competing residue uses. At current conditions, the sustainable bioenergy potential from maize and wheat residues was estimated to be about 104 PJ. There is potential to increase the amount of crop residues to 238 PJ through measures such as no till cultivation and adopting improved cropping systems. These estimates were based on minimum residues requirements of 2 t ha−1 for soil erosion control and additional residue amounts to maintain 2% SOC level.At the farm gate, crop residues cost between 0.9 and 1.7 $GJ−1. About 96$ GJ−1. In the improved scenario, up to 85% of the biomass is below 1.3 $GJ−1. For biomass deliveries at the conversion plant, about 36$ GJ−1 while in the optimised scenario, about 87% is delivered below 5$ GJ−1. Co-firing residues with coal results in lower cost of electricity compared to other renewables and significant GHG (CO2 eq) emissions reduction (up to 0.72 tons MWh−1). Establishing sustainable crop residue supply systems in South Africa could start by utilising the existing agricultural infrastructure to secure supply and develop a functional market. It would then be necessary to incentivise improvements across the value chain

Both raloxifene and estrogen reduce major cardiovascular risk factors in healthy postmenopausal women; A 2 year, placebo-controlled study

Currently raloxifene, a selective estrogen receptor modulator, is being investigated as a potential alternative for postmenopausal hormone replacement to prevent osteoporosis and cardiovascular disease. We compared the 2-year effects of raloxifene on a wide range of cardiovascular risk factors with those of placebo and conjugated equine estrogens (CEEs). Analyses were based on 56 hysterectomized but otherwise-healthy postmenopausal women aged 54.8±3.5 (mean±SD) years who entered this double- blind study and who were randomly assigned to raloxifene hydrochloride 60 mg/d (n = 15) or 150 mg/d (n= 13), placebo (n= 13), or CEEs 0.625 mg/d (n = 15). At baseline and after 6, 12, and 24 months of treatment, we assessed serum lipids, blood pressure, glucose metabolism, C-reactive protein, and various hemostatic parameters. Compared with placebo, both raloxifene and CEEs lowered the level of low density lipoprotein cholesterol by 0.53 to 0.79 mmol/L (all P<0.04) and lowered, at 24 months, the level of fibrinogen by 0.71 to 0.86 g/L (all P<0.05). The effects of raloxifene and CEEs did not differ significantly. In contrast to raloxifene, from 6 months on CEEs increased high density lipoprotein cholesterol by 0.25 to 0.29 mmol/L and reduced plasminogen activator inhibitor-1 antigen by 30.6 to 48.6 ng/mL (all P<0.02 versus both placebo and raloxifene). CEEs transiently increased C- reactive protein by 1.0 mg/L at 6 months (P<0.05 versus placebo) and- prothrombin-derived fragment F1 +2 by 0.79 nmol/L at 12 months (P<0.001 versus placebo). Finally, from 12 months on, CEEs increased triglycerides by 0.33 to 0.56 mmol/L (all P<0.05 versus both placebo and raloxifene). Our findings suggest that in healthy postmenopausal women, raloxifene and estrogen monotherapy have similar beneficial effects on low density lipoprotein cholesterol and fibrinogen levels. These treatments differ, however, in their effects on high density lipoprotein cholesterol, triglycerides, and plasminogen activator inhibitor-1 and possibly in their effects on prothrombin fragment F1+2 and C-reactive protein

High Resolution Genotyping of Clinical Aspergillus flavus Isolates from India Using Microsatellites

Contains fulltext : 124312.pdf (publisher's version ) (Open Access)BACKGROUND: Worldwide, Aspergillus flavus is the second leading cause of allergic, invasive and colonizing fungal diseases in humans. However, it is the most common species causing fungal rhinosinusitis and eye infections in tropical countries. Despite the growing challenges due to A. flavus, the molecular epidemiology of this fungus has not been well studied. We evaluated the use of microsatellites for high resolution genotyping of A. flavus from India and a possible connection between clinical presentation and genotype of the involved isolate. METHODOLOGY/PRINCIPAL FINDINGS: A panel of nine microsatellite markers were selected from the genome of A. flavus NRRL 3357. These markers were used to type 162 clinical isolates of A. flavus. All nine markers proved to be polymorphic displaying up to 33 alleles per marker. Thirteen isolates proved to be a mixture of different genotypes. Among the 149 pure isolates, 124 different genotypes could be recognized. The discriminatory power (D) for the individual markers ranged from 0.657 to 0.954. The D value of the panel of nine markers combined was 0.997. The multiplex multicolor approach was instrumental in rapid typing of a large number of isolates. There was no correlation between genotype and the clinical presentation of the infection. CONCLUSIONS/SIGNIFICANCE: There is a large genotypic diversity in clinical A. flavus isolates from India. The presence of more than one genotype in clinical samples illustrates the possibility that persons may be colonized by multiple genotypes and that any isolate from a clinical specimen is not necessarily the one actually causing infection. Microsatellites are excellent typing targets for discriminating between A. flavus isolates from various origins

231Pa and 230Th in the Arctic Ocean 1991-2015: Changes in the Eurasian and Makarov Basins

230Th and 231Pa are produced in sea water by radioactive decay of Uranium isotopes (234U, 235U). Both are particle reactive and are scavenged onto settling particles. As 230Th is more particle reactive than 231Pa, their distribution in the water column and activity ratio give information about particle fluxes and circulation patterns and –intensities. Both particle fluxes and deep water circulation may respond to climatic changes in the Arctic Ocean. This study discusses temporal changes in radionuclide concentration in the context of climate change. We compare results from 1991 [1] 2007 and 2015. We present results of dissolved 231Pa and 230Th activities of samples collected in the Nansen-, Amundsenand Makarov Basins during GEOTRACES sections GIPY11 (2007, 4 stations), GN04 (2015, 10 stations) aboard RV Polarstern. Our discussion of factors controlling the 230Th and 231Pa distribution is supported by, dissolved CFC, dissolved iron and particulate 230Th and 231Pa (3 stations) collected during GEOTRACES section GN04. We find that distributions and concentrations of dissolved 231Pa and 230Th in the central Arctic Ocean have changed significantly since 1991. Dissolved 231Pa concentrations in the Makarov basin decreased by half within less than 20 years. These changes are discussed in the context of environmental changes, such as declining sea ice cover and related increase of particle fluxes or changing deep water circulation. [1] Scholten, J. C., et al. (1995). Deep-Sea Research II 42: 1519- 153

Clinical and Angiographic Factors Associated With Asymptomatic Restenosis After Percutaneous Coronary Intervention

BACKGROUND: Angiographic restenosis after percutaneous coronary interventional procedures is more common than recurrent angina. Clinical and angiographic factors associated with asymptomatic versus symptomatic restenosis after percutaneous coronary intervention were compared. METHODS AND RESULTS: All patients with angiographic restenosis from the BENESTENT I, BENESTENT II pilot, BENESTENT II, MUSIC, WEST 1, DUET, FINESS 2, FLARE, SOPHOS, and ROSE studies were analyzed. Multivariate analysis evaluated 46 clinical and angiographic variables, comparing those with and without angina. The 10 studies recruited 2690 patients who underwent percutaneous revascularization and 6-month follow-up angiography (86% of those eligible). Restenosis (>/=50% diameter stenosis) occurred in 607 patients and was clinically silent in 335 (55%). Male sex (P=0.008), absence of antianginal therapy with nitrates (P=0.0002) and calcium channel blockers (P=0.02) at 6 months, greater reference diameter after the procedure (P=0.04), greater reference diameter at follow-up (P=0.004), and lesser lesion severity (percent stenosis) at 6 months (P=0.0004) were univariate predictors of asymptomatic restenosis. By multivariate analysis, only male sex (P=0.04), greater reference diameter at follow-up (P=0.002), and lesser lesion severity at 6 months (P=0.0001) were associated with restenosis without angina. CONCLUSIONS: Approximately half of patients with angiographic restenosis have no symptoms. The only multivariate predictors of silent restenosis at 6 months were male sex, greater reference diameter at follow-up, and lesser lesion severity on follow-up angiography